162 related articles for article (PubMed ID: 23268707)
1. Different cell cycle modulation by celecoxib at different concentrations.
Kim YM; Pyo H
Cancer Biother Radiopharm; 2013 Mar; 28(2):138-45. PubMed ID: 23268707
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
[TBL] [Abstract][Full Text] [Related]
3. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
4. Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib.
Jun HJ; Kim YM; Park SY; Park JS; Lee EJ; Choi SA; Pyo H
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):225-34. PubMed ID: 19695440
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823].
Li Q; Peng J; Zhang GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1123-8. PubMed ID: 19141979
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
[TBL] [Abstract][Full Text] [Related]
7. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
8. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells.
Park JS; Jun HJ; Cho MJ; Cho KH; Lee JS; Zo JI; Pyo H
Clin Cancer Res; 2006 Aug; 12(16):4989-99. PubMed ID: 16914589
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells.
Dhawan D; Jeffreys AB; Zheng R; Stewart JC; Knapp DW
Mol Cancer Ther; 2008 Apr; 7(4):897-904. PubMed ID: 18413803
[TBL] [Abstract][Full Text] [Related]
11. Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.
Ramer R; Walther U; Borchert P; Laufer S; Linnebacher M; Hinz B
J Lipid Res; 2013 Nov; 54(11):3116-29. PubMed ID: 23943857
[TBL] [Abstract][Full Text] [Related]
12. [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism].
Xie X; Li J; Wang RC; Geng RL; Wang SY; Wang C; Zhao XY; Hao HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):707-11. PubMed ID: 24989281
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.
Lim YJ; Rhee JC; Bae YM; Chun WJ
World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
15. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
[TBL] [Abstract][Full Text] [Related]
16. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration.
Kuipers GK; Slotman BJ; Wedekind LE; Stoter TR; Berg Jv; Sminia P; Lafleur MV
Int J Radiat Biol; 2007 Oct; 83(10):677-85. PubMed ID: 17729162
[TBL] [Abstract][Full Text] [Related]
20. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
